Calidi Biotherapeutics, Inc. cotiza a 0.95 USD y tiene una capitalización bursátil de $3M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for r…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | $-35.36 | $-31.89 | $-35.94 | $-51.84 |
| Estimado | $-26.88 | $-21.12 | $-28.80 | $-71.04 |
| Sorpresa | -31.5% | -51.0% | -24.8% | +27.0% |
| Métrica | CLDI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -529.6% | -40.4% | -489.2% |
| ROA | -224.8% | -32.0% | -192.7% |
| Current Ratio | 1.59 | 2.84 | -1.25 |
| Debt / Equity | 0.16 | 0.28 | -0.12 |